Literature DB >> 2185491

Pharmacology of cyclosporine (sandimmune). V. Pharmacological effects on immune function: in vitro studies.

F E Di Padova1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185491

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  9 in total

Review 1.  The spectrum of action of new immunosuppressive drugs.

Authors:  A W Thomson
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 2.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

3.  Inhaled cyclosporine and pulmonary function in lung transplant recipients.

Authors:  Soleyah Groves; Marek Galazka; Bruce Johnson; Timothy Corcoran; Avelino Verceles; Edward Britt; Nevins Todd; Bartley Griffith; Gerald C Smaldone; Aldo Iacono
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-02       Impact factor: 2.849

Review 4.  New immunosuppressive drugs: mechanistic insights and potential therapeutic advances.

Authors:  A W Thomson; T E Starzl
Journal:  Immunol Rev       Date:  1993-12       Impact factor: 12.988

Review 5.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs.

Authors:  W T Klimecki; C W Taylor; W S Dalton
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

Review 7.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

8.  Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.

Authors:  S E Roselaar; G Schonfeld; A Daugherty
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.

Authors:  S Yano; S Sone; Y Nishioka; M Naito; T Tsuruo; T Ogura
Journal:  Jpn J Cancer Res       Date:  1994-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.